Trxade Group Performance
| MEDSDelisted Stock | USD 7.46 0.56 8.12% |
The entity has a beta of 0.8, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Trxade's returns are expected to increase less than the market. However, during the bear market, the loss of holding Trxade is expected to be smaller as well. At this point, Trxade Group has a negative expected return of -0.0794%. Please make sure to validate Trxade's potential upside, rate of daily change, as well as the relationship between the Rate Of Daily Change and period momentum indicator , to decide if Trxade Group performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Trxade Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, Trxade is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors. ...more
| Begin Period Cash Flow | 1.1 M | |
| Free Cash Flow | -2.1 M |
Trxade |
Trxade Relative Risk vs. Return Landscape
If you would invest 774.00 in Trxade Group on August 27, 2024 and sell it today you would lose (28.00) from holding Trxade Group or give up 3.62% of portfolio value over 90 days. Trxade Group is currently does not generate positive expected returns and assumes 3.9333% risk (volatility on return distribution) over the 90 days horizon. In different words, 35% of stocks are less volatile than Trxade, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Trxade Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Trxade's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Trxade Group, and traders can use it to determine the average amount a Trxade's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0202
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | MEDS |
Estimated Market Risk
| 3.93 actual daily | 34 66% of assets are more volatile |
Expected Return
| -0.08 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Trxade is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Trxade by adding Trxade to a well-diversified portfolio.
Trxade Fundamentals Growth
Trxade Stock prices reflect investors' perceptions of the future prospects and financial health of Trxade, and Trxade fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Trxade Stock performance.
| Return On Equity | -2.69 | |||
| Return On Asset | -0.72 | |||
| Profit Margin | 0.57 % | |||
| Operating Margin | (79.99) % | |||
| Current Valuation | 5.69 M | |||
| Shares Outstanding | 1.75 M | |||
| Price To Book | 1.12 X | |||
| Price To Sales | 1.78 X | |||
| Revenue | 8.27 M | |||
| EBITDA | (6.19 M) | |||
| Cash And Equivalents | 962.23 K | |||
| Cash Per Share | 0.12 X | |||
| Total Debt | 7.1 M | |||
| Debt To Equity | 0.93 % | |||
| Book Value Per Share | 8.38 X | |||
| Cash Flow From Operations | (2.07 M) | |||
| Earnings Per Share | (24.38) X | |||
| Total Asset | 12.53 M | |||
| Retained Earnings | (33.25 M) | |||
| Current Asset | 1.12 M | |||
| Current Liabilities | 49 K | |||
About Trxade Performance
Assessing Trxade's fundamental ratios provides investors with valuable insights into Trxade's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Trxade is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. Trxade Health operates under Pharmaceutical Retailers classification in the United States and is traded on NASDAQ Exchange. It employs 47 people.Things to note about Trxade Group performance evaluation
Checking the ongoing alerts about Trxade for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Trxade Group help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Trxade Group is now traded under the symbol SCNX. Please update your portfolios or report it if you believe this is an error. Report It! | |
| Trxade Group is not yet fully synchronised with the market data | |
| Trxade Group generated a negative expected return over the last 90 days | |
| Trxade Group has high historical volatility and very poor performance | |
| Trxade Group has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 8.27 M. Net Loss for the year was (13.72 M) with profit before overhead, payroll, taxes, and interest of 4.58 M. | |
| Trxade Group currently holds about 962.23 K in cash with (2.07 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.12. | |
| Roughly 62.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Trxade's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Trxade's stock is overvalued or undervalued compared to its peers.
- Examining Trxade's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Trxade's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Trxade's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Trxade's stock. These opinions can provide insight into Trxade's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Consideration for investing in Trxade Stock
If you are still planning to invest in Trxade Group check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Trxade's history and understand the potential risks before investing.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |